Who is eligible for clinical trial NCT07361432?

Participants must meet protocol criteria for Opioid Use Disorder. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT07361432 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-01-27

Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine (NCT07361432)

🟡 Not Yet Recruiting Phase3 🧠 Behavioral & Psychological Program Sponsor: VA Office of Research and Development

🩺 Plain-English Summary (8th-Grade Level)

Chronic pain is common in individuals with opioid use disorder (OUD) and the first-line treatment, Medication for OUD (MOUD), does not address the considerable functional impairments associated with chronic pain. Veterans with OUD and chronic pain could benefit from integrated, behavioral treatment for chronic pain and addiction, but VHA MOUD clinics often lack the resources to offer these services. The proposed study will examine the effectiveness of an evidence-based digital chronic pain and addiction treatment that Veterans can do from home, which can provide a flexible option for Veterans to engage in treatment from home and the Veterans Health Administration (VHA) a means to provide care without placing trained clinicians at each facility.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (7 items).

Location: VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

an ICD-11 OUD diagnosis in the VHA electronic health record (EHR)
receipt of buprenorphine from outpatient addiction clinic with stable (i.e., unchanged in 2 weeks or since last injection) dose confirmed by the prescribing clinician. Both oral and injectable buprenorphine formulations will be eligible with dose stabilization required to isolate chronic pain from withdrawal-related pain associated with non-therapeutic dose
presence of musculoskeletal pain that is bothersome or high-impact per the Graded Pain Scale - Revised
access to a web-connected device to complete daily surveys and connect to IMPACT treatment site
ability to participate safely in the walking portion of the intervention as evidenced by patient-reported ability to walk at least one block

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
dementia-related EHR diagnosis
participant-reported vision or hearing impairments that would preclude use of the IMPACT system
legal actions that would make study completion unlikely
current or past 12 month engagement in CBT for chronic pain treatment
planned surgical intervention for pain
physical or mental health conditions that would interfere with ability to meaningful engage in IMPACT and MOUD treatment (e.g., uncontrolled bipolar disorder, active suicidal ideation, receipt of hospice or end-of-life palliative care)

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (4 Sites)

VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut
VA Bedford HealthCare System, Bedford, MA — Bedford, Massachusetts
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA — Boston, Massachusetts
VA Portland Health Care System, Portland, OR — Portland, Oregon

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗